Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06570941 · ClinicalTrials.gov registry record · Phase 1
Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome
A Phase 1 study of Restless Legs Syndrome, sponsored by Synthonics.
- Active
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06570941 is a Phase 1 study of Restless Legs Syndrome that is active but no longer recruiting, run by Synthonics. The registered enrollment target is 10 participants, below the 96-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06570941, a Phase 1 study of Restless Legs Syndrome, is active but no longer recruiting, sponsored by Synthonics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this open label clinical trial is to reduce the effects of restless leg syndrome. The main it questions it aims to answer are: 1. Reduce or eliminate the symptoms of restless leg syndrome. 2. Improve the quality of life of participants with restless leg syndrome. Participants will be asked to apply the topical cream to the affected area 30 to 45 minutes before bedtime for 14 consecutive days.
Conditions Studied
Interventions
- DRUG Chylobinoid Topical Cream
Study Locations (1)
Florida
- Synthonics - Sarasota
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2024-10-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06570941
The ClinicalTrials.gov registry entry for NCT06570941 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 96-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (90% lower). The listed sponsor is Synthonics, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Restless Legs Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Chylobinoid Topical Cream is the first listed.
NCT06570941 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT06570941 about?
NCT06570941 is a clinical study titled "Benefits of a Cannabidiolic Acid Topical Cream for the Treatment of Restless Leg Syndrome". The goal of this open label clinical trial is to reduce the effects of restless leg syndrome. The main it questions it aims to answer are: 1. Reduce or eliminate the symptoms of restless leg syndrome. 2. Improve the quality of life of participants with restless leg syndrome. Participants will be a...
What is the current status of trial NCT06570941?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2024-03-01. Estimated completion is 2024-10-31.
What conditions does trial NCT06570941 study?
This clinical trial studies the following conditions: Restless Legs Syndrome.
What interventions are being tested in trial NCT06570941?
The interventions under investigation include: Chylobinoid Topical Cream (DRUG).
Who is sponsoring clinical trial NCT06570941?
This trial is sponsored by Synthonics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06570941 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Restless Legs Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study To Investigate The Effects Of End Stage Renal Disease And Hemodialysis On The Pharmacokinetics Of Ropinirole
COMPLETED · Phase 1
-
A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers
COMPLETED · Phase 1
-
Blood Changes After Exercise in Restless Legs Syndrome
RECRUITING · NA
-
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
ACTIVE NOT RECRUITING · Phase 4
-
Response to an Investigational Device in Patients With Restless Legs Syndrome
ACTIVE NOT RECRUITING · NA
-
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.